Ticker

Analyst Price Targets — MRMD

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
April 15, 2022 12:00 amKyle BauserColliers Securities$2.25$0.72TipRanks Contributor MariMed Gets Nod to Acquire Cannabis Company; Street Sees 159% Upside

Latest News for MRMD

MariMed Announces Second Quarter 2026 Earnings Date

NORWOOD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”) (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its second quarter 2026 financial results on August 12, 2026 after the markets close.

GlobeNewsWire • Jul 15, 2026
MariMed Announces Second Quarter 2026 Earnings Date

NORWOOD, Mass. , July 15, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQB: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today it will report its second quarter 2026 financial results on August 12, 2026 after the markets close.

Globe News Wire • Jul 15, 2026
MariMed's Nature's Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign

NORWOOD, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- MariMed's (“MariMed”) (CSE: MRMD) (OTCQB: MRMD) award-winning flower, vape and concentrate brand, Nature's Heritage™ , today announced the launch of ‘The Nose Knows,' an immersive, science-backed consumer education campaign designed to help consumers better understand which cannabis products and strains align best to their preferences.

GlobeNewsWire • Jul 7, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for MRMD.

No House trades found for MRMD.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top